0002071237-26-000002.txt : 20260312 0002071237-26-000002.hdr.sgml : 20260312 20260312173005 ACCESSION NUMBER: 0002071237-26-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20260312 FILED AS OF DATE: 20260312 DATE AS OF CHANGE: 20260312 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fitzgerald Lindsay Clinton CENTRAL INDEX KEY: 0002071237 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35073 FILM NUMBER: 26749141 MAIL ADDRESS: STREET 1: C/O GEVO, INC. 345 INVERNESS DRIVE SOUTH STREET 2: BUILDING C, SUITE 310 CITY: ENGLEWOOD STATE: CO ZIP: 80112 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Gevo, Inc. CENTRAL INDEX KEY: 0001392380 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 870747704 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 345 INVERNESS DRIVE SOUTH, BUILDING C STREET 2: Suite 310 CITY: ENGLEWOOD STATE: CO ZIP: 80112 BUSINESS PHONE: 303-858-8358 MAIL ADDRESS: STREET 1: 345 INVERNESS DRIVE SOUTH, BUILDING C STREET 2: Suite 310 CITY: ENGLEWOOD STATE: CO ZIP: 80112 FORMER COMPANY: FORMER CONFORMED NAME: Gevo Inc DATE OF NAME CHANGE: 20070307 4 1 form4-03122026_050301.xml X0508 4 2026-03-12 0001392380 Gevo, Inc. GEVO 0002071237 Fitzgerald Lindsay Clinton C/O GEVO, INC. 345 INVERNESS DRIVE SOUTH BUILDING C, SUITE 310 ENGLEWOOD CO 80112 false true false false Chief Public Affairs Officer 1 Common Stock 2026-03-12 4 S 0 20000 2.5062 D 212199 D Common Stock 20624.27 I By 401(k) Plan The reported transactions were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.50 to $2.515 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Between August 5, 2025 and March 12, 2026, the reporting person (i) acquired 7,329.85 shares of the issuer's common stock under the issuer's 401(k) plan; and (ii) disposed of 35.32 shares of the issuer's common stock under the issuer's 401(k) plan to cover administrative fees. The information in this report is based on a plan statement dated February 27, 2026. /s/ E. Cabell Massey, Attorney-in-Fact 2026-03-12